Image Image Image Image Image
Scroll to Top

To Top

Blog

26

Jan
2016

No Comments

In Blog
GMO Labeling

By Admin

Our View: No reason Maine should speed up GMO labeling

On 26, Jan 2016 | No Comments | In Blog, GMO Labeling | By Admin

Nothing’s changed since then, except for further confirmation of the safety of foods containing GMOs. So it remains unnecessary to eliminate the trigger clause – the part of the labeling mandate that relies on other states – as proposed in a new bill, L.D. 991.

However, we do support the other provision of L.D. 991. It would revoke a clause automatically repealing the original law if the other states don’t pass legislation by 2018, thus allowing Maine to continue to stand as a supporter of reasonable transparency on food labels.

Full Story Here

Submit a Comment

Latest News

Bangor Daily News: University of Maine to train military veterans in farming

November 23, 2020 by Admin


by The Associated Press November 22, 2020

ORONO, Maine — The University of Maine is launching a program to offer training in food production to military veterans and farmers with disabilities.

The program is called “Boots-2-Bushels: Boot Camp for Market Gardeners and Farmers,” the University of Maine Cooperative Extension said. It is slated to begin in January and will focus on training in small-scale farming for market sales, the extension said.

The program will take place online through May 24 and include hands-on fieldwork from May to September. The extension said the program will include training in subjects such as crop planning, safe food handling and pest management.

Read More:

BARDA, Department of Defense, and SAb Biotherapeutics to Partner to Develop a Novel COVID-19 Therapeutic

April 6, 2020 by Admin

Published by Medical Counter Measures

A therapeutic to treat novel coronavirus disease 2019 (COVID-19) is moving forward in development through a partnership between BARDA, the Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO – CBRND), and SAb Biotherapeutics, Inc. (SAb), of Sioux Falls, South Dakota.

Using an interagency agreement with JPEO’s Medical CBRN Defense Consortium, BARDA transferred approximately $7.2 million in funding to (JPEO – CBRND) to support SAb to complete manufacturing and preclinical studies, with an option to conduct a Phase 1 clinical trial.

Read the full press release here.

Agri-Pulse: Can cows be used to fight coronavirus?

March 30, 2020 by Admin

Bovine plasma donors genetically engineered to produce human antibodies are in the front lines of the struggle against coronavirus.

SAB Biotherapeutics, a Sioux Falls, S.D., biotechnology company that has been successfully testing use of antibodies from cows to fight diseases such as another coronavirus, Middle East respiratory syndrome, now is engaged in developing a treatment for COVID-19, the disease caused by the novel coronavirus.

Read the full article here.

Categories